Skip to menu Skip to content Skip to footer
Dr

Johanna Richter

Email: 
Phone: 
+61 7 344 36273

Overview

Availability

Dr Johanna Richter is:
Available for supervision

Qualifications

  • Bachelor of Molecular Medicine, Universität Ulm
  • Masters (Coursework) of Medical Sciences, Newcastle University
  • Doctor of Philosophy of Microbiology, The University of Queensland

Works

Search Professor Johanna Richter’s works on UQ eSpace

10 works between 2019 and 2025

1 - 10 of 10 works

2025

Journal Article

An mRNA vaccine encoding five conserved Group A Streptococcus antigens

Harbison-Price, Nichaela, Sebina, Ismail, Bolton, Rhiannon A., Finn, Meredith, Cork, Amanda J., Courtney, Isabel G., Hancock, Steven, Pelingon, Ruby, Richter, Johanna, Ericsson, Olivia, Green, Shannon, Cuellar, Celeste, Davis, Laura, Pullinger, Brody, Na, Jack, Elangovan, Gayathiri, De Oliveira, David M. P., Curren, Bodie F., Bickham, Nia, Aguirre, Miguel, Dold, Christina, Brouwer, Stephan, Plante, Obadiah, Belz, Gabrielle T. and Walker, Mark J. (2025). An mRNA vaccine encoding five conserved Group A Streptococcus antigens. Nature Communications, 16 (1) 5439, 1-14. doi: 10.1038/s41467-025-60580-0

An mRNA vaccine encoding five conserved Group A Streptococcus antigens

2025

Journal Article

Characterization of a novel covS SNP identified in Australian group A Streptococcus isolates derived from the M1 UK lineage

Richter, Johanna, Cork, Amanda J., Ong, Yvette, Keller, Nadia, Hayes, Andrew J., Schembri, Mark A., Jennison, Amy V., Davies, Mark R., Schroder, Kate, Walker, Mark J. and Brouwer, Stephan (2025). Characterization of a novel covS SNP identified in Australian group A Streptococcus isolates derived from the M1 UK lineage. mBio, 16 (2) e0336624, e0336624. doi: 10.1128/mbio.03366-24

Characterization of a novel covS SNP identified in Australian group A Streptococcus isolates derived from the M1 UK lineage

2024

Journal Article

Efficacy of alum-adjuvanted peptide and carbohydrate conjugate vaccine candidates against Group A Streptococcus pharyngeal infection in a non-human primate model

Rivera-Hernandez, Tania, Carnathan, Diane G., Richter, Johanna, Marchant, Patrick, Cork, Amanda J., Elangovan, Gayathiri, Henningham, Anna, Cole, Jason N., Choudhury, Biswa, Moyle, Peter M., Toth, Istvan, Batzloff, Michael R., Good, Michael F., Agarwal, Paresh, Kapoor, Neeraj, Nizet, Victor, Silvestri, Guido and Walker, Mark J. (2024). Efficacy of alum-adjuvanted peptide and carbohydrate conjugate vaccine candidates against Group A Streptococcus pharyngeal infection in a non-human primate model. Vaccines, 12 (4) 382, 1-10. doi: 10.3390/vaccines12040382

Efficacy of alum-adjuvanted peptide and carbohydrate conjugate vaccine candidates against Group A Streptococcus pharyngeal infection in a non-human primate model

2023

Other Outputs

Characterisation of the interaction of M1 Group A Streptococcus with the inflammasome pathway

Richter, Johanna (2023). Characterisation of the interaction of M1 Group A Streptococcus with the inflammasome pathway. PhD Thesis, School of Chemistry and Molecular Biosciences, The University of Queensland. doi: 10.14264/1a77be5

Characterisation of the interaction of M1 Group A Streptococcus with the inflammasome pathway

2021

Journal Article

Streptolysins are the primary inflammasome activators in macrophages during Streptococcus pyogenes infection

Richter, Johanna, Monteleone, Mercedes M, Cork, Amanda J., Barnett, Timothy C., Nizet, Victor, Brouwer, Stephan, Schroder, Kate and Walker, Mark J. (2021). Streptolysins are the primary inflammasome activators in macrophages during Streptococcus pyogenes infection. Immunology and Cell Biology, 99 (10), 1-13. doi: 10.1111/imcb.12499

Streptolysins are the primary inflammasome activators in macrophages during Streptococcus pyogenes infection

2021

Journal Article

Inflammasome activation and IL ‐1β signalling in Group A Streptococcus disease

Richter, Johanna, Brouwer, Stephan, Schroder, Kate and Walker, Mark J. (2021). Inflammasome activation and IL ‐1β signalling in Group A Streptococcus disease. Cellular Microbiology, 23 (9) e13373, 1-9. doi: 10.1111/cmi.13373

Inflammasome activation and IL ‐1β signalling in Group A Streptococcus disease

2020

Journal Article

Prophage exotoxins enhance colonization fitness in epidemic scarlet fever-causing Streptococcus pyogenes

Brouwer, Stephan, Barnett, Timothy C., Ly, Diane, Kasper, Katherine J., De Oliveira, David M. P., Rivera-Hernandez, Tania, Cork, Amanda J., McIntyre, Liam, Jespersen, Magnus G., Richter, Johanna, Schulz, Benjamin L., Dougan, Gordon, Nizet, Victor, Yuen, Kwok-Yung, You, Yuanhai, McCormick, John K., Sanderson-Smith, Martina L., Davies, Mark R. and Walker, Mark J. (2020). Prophage exotoxins enhance colonization fitness in epidemic scarlet fever-causing Streptococcus pyogenes. Nature Communications, 11 (1) 5018, 5018. doi: 10.1038/s41467-020-18700-5

Prophage exotoxins enhance colonization fitness in epidemic scarlet fever-causing Streptococcus pyogenes

2020

Journal Article

Preclinical evaluation of a novel SHIP1 phosphatase activator for inhibition of PI3K signaling in malignant B cells

Lemm, Elizabeth A., Valle-Argos, Beatriz, Smith, Lindsay D., Richter, Johanna, Gebreselassie, Yohannes, Carter, Matthew J., Karolova, Jana, Svaton, Michael, Helman, Karel, Weston-Bell, Nicola J., Karydis, Laura, Williamson, Chris T., Lenz, Georg, Pettigrew, Jeremy, Harwig, Curtis, Stevenson, Freda K., Cragg, Mark, Forconi, Francesco, Steele, Andrew J., Cross, Jennifer, Mackenzie, Lloyd, Klener, Pavel and Packham, Graham (2020). Preclinical evaluation of a novel SHIP1 phosphatase activator for inhibition of PI3K signaling in malignant B cells. Clinical Cancer Research, 26 (7), 1700-1711. doi: 10.1158/1078-0432.ccr-19-2202

Preclinical evaluation of a novel SHIP1 phosphatase activator for inhibition of PI3K signaling in malignant B cells

2020

Journal Article

Vaccine-induced Th1-type response protects against invasive group A Streptococcus infection in the absence of opsonizing antibodies

Rivera-Hernandez, Tania, Rhyme, Mira Syahira, Cork, Amanda J., Jones, Scott, Segui-Perez, Celia, Brunner, Livia, Richter, Johanna, Petrovsky, Nikolai, Lawrenz, Maria, Goldblatt, David, Collin, Nicolas and Walker, Mark J. (2020). Vaccine-induced Th1-type response protects against invasive group A Streptococcus infection in the absence of opsonizing antibodies. mBio, 11 (2) e00122-20. doi: 10.1128/mbio.00122-20

Vaccine-induced Th1-type response protects against invasive group A Streptococcus infection in the absence of opsonizing antibodies

2019

Journal Article

Detection of epidemic scarlet fever group A Streptococcus in Australia

Walker, Mark J., Brouwer, Stephan, Forde, Brian M., Worthing, Kate A., McIntyre, Liam, Sundac, Lana, Maloney, Sam, Roberts, Leah W., Barnett, Timothy C., Richter, Johanna, Cork, Amanda J., Irwin, Adam D., You, Yuanhai, Zhang, Jianzhong, Dougan, Gordon, Yuen, K. Y., Nizet, Victor, Beatson, Scott A., Grimwood, Keith and Davies, Mark R. (2019). Detection of epidemic scarlet fever group A Streptococcus in Australia. Clinical Infectious Diseases, 69 (7), 1232-1234. doi: 10.1093/cid/ciz099

Detection of epidemic scarlet fever group A Streptococcus in Australia

Supervision

Availability

Dr Johanna Richter is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Media

Enquiries

For media enquiries about Dr Johanna Richter's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au